Open access
50
Views
0
CrossRef citations to date
0
Altmetric
RESPONSE TO LETTER
Response to: “Challenges in DPYD Test Implementation in Patients Treated with Fluoropyirimidines, is DPYD Genotype Arriving on Time?” [Response to Letter]
Cristina Montrasio1 Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco, L. Sacco University Hospital, Milan, ItalyCorrespondence[email protected]
https://orcid.org/0000-0002-8276-3663
, https://orcid.org/0000-0002-8276-3663
Stefania Cheli1 Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco, L. Sacco University Hospital, Milan, Italyhttps://orcid.org/0000-0002-2837-5248
& Emilio Clementi2 Clinical Pharmacology Unit, Department of Biomedical and Clinical Sciences, L. Sacco University Hospital, Università degli Studi di Milano, Milan, Italy;3 Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Italy
Pages 51-52
|
Received 22 Dec 2023, Accepted 09 Jan 2024, Published online: 31 Jan 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.